974 related articles for article (PubMed ID: 26105198)
1. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
[TBL] [Abstract][Full Text] [Related]
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
5. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
[TBL] [Abstract][Full Text] [Related]
7. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.
Heinisch C; Bertog S; Wunderlich N; Majunke N; Baranowski A; Leetz M; Fischer E; Staubach S; Zimmermann W; Hofmann I; Sievert H
EuroIntervention; 2012 Oct; 8(6):717-23. PubMed ID: 23086790
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.
Ford MA; Reeder GS; Lennon RJ; Brown RD; Petty GW; Cabalka AK; Cetta F; Hagler DJ
JACC Cardiovasc Interv; 2009 May; 2(5):404-11. PubMed ID: 19463462
[TBL] [Abstract][Full Text] [Related]
10. Ten years of experience with closure of persistent foramen ovale: patient characteristics and outcomes.
Lehmann R; Fichtlscherer S; Baldauf H; Schächinger V; Auch-Schwelck W; Zeiher AM; Teupe C
J Cardiol; 2014 Aug; 64(2):113-6. PubMed ID: 24480741
[TBL] [Abstract][Full Text] [Related]
11. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
12. Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Dellborg M
Int J Cardiol; 2015 Sep; 195():293-9. PubMed ID: 26056962
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
Sitwala P; Khalid MF; Khattak F; Bagai J; Bhogal S; Ladia V; Mukherjee D; Daggubati R; Paul TK
Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
[TBL] [Abstract][Full Text] [Related]
14. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
Davies A; Ekmejian A; Collins N; Bhagwandeen R
Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
[TBL] [Abstract][Full Text] [Related]
16. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
[TBL] [Abstract][Full Text] [Related]
18. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.
Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L;
Stroke; 2010 Dec; 41(12):2872-83. PubMed ID: 21051670
[TBL] [Abstract][Full Text] [Related]
19. Very long-term follow-up after percutaneous closure of patent foramen ovale.
Eeckhout E; Martin S; Delabays A; Michel P; Girod G
EuroIntervention; 2015 Apr; 10(12):1474-9. PubMed ID: 24429213
[TBL] [Abstract][Full Text] [Related]
20. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials.
Wang TKM; Wang MTM; Ruygrok P
Heart Lung Circ; 2019 Apr; 28(4):623-631. PubMed ID: 29602754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
